E5KT65 (E5KT65_HUMAN) Homo sapiens (Human)

DNA-directed RNA polymerase II subunit E UniProtKBProtein AtlasInterProInteractive Modelling

210 aa; Sequence (Fasta) ; 1 identical sequence: Homo sapiens: P19388

Available Structures

33 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Cryo-EM structure of human RNA Polymerase I in complex with RRN3 Heteromer
O15160; O15446; O95602; P0DPB6; P19388; P52434; P53803; P61218; P62875; Q3B726; Q9GZS1; Q9H9Y6; Q9NYV6; Q9P1U0;
1-210
99.52ZN;
Human holo-PIC in the initial transcribing state Heteromer
O15514; P13984; P18074; P19387; P19388; P19447; P20226; P23193; P24928; P29083; P29084; P30876; P35269; P36954; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403; Q13888; Q13889; Q6ZYL4; Q92759;
1-210
100MG; 11×ZN;
cryo-EM structure of human RNA polymerase III in apo state Heteromer
O14802; O15160; O15318; O75575; P05423; P0DPB6; P19388; P52434; P53803; P61218; P62875; Q9BUI4; Q9H1D9; Q9NVU0; Q9NW08; Q9Y2Y1; Q9Y535;
1-210
100ZN;SF4;
Cryo-EM structure of human RNA Polymerase I Open Complex Heteromer
O15160; O15446; O95602; P0DPB6; P19388; P52434; P53803; P61218; P62875; Q3B726; Q9GZS1; Q9H9Y6; Q9P1U0;
1-210
99.52ZN;
Human holo-PIC in the initial transcribing state (no IIS) Heteromer
O15514; P13984; P18074; P19387; P19388; P19447; P20226; P24928; P29083; P29084; P30876; P35269; P36954; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403; Q13888; Q13889; Q6ZYL4; Q92759;
1-210
100MG; 10×ZN;
Human core-PIC in the open state Heteromer
O15514; P13984; P19387; P19388; P20226; P23193; P24928; P29083; P29084; P30876; P35269; P36954; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403;
1-210
100MG; 11×ZN;
Human holo-PIC in the closed state Heteromer
O15514; P13984; P18074; P19387; P19388; P19447; P20226; P23193; P24928; P29083; P29084; P30876; P35269; P36954; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403; Q13888; Q13889; Q6ZYL4; Q92759;
1-210
100MG; 11×ZN;
Human holo-PIC in the open state Heteromer
O15514; P13984; P18074; P19387; P19388; P19447; P20226; P23193; P24928; P29083; P29084; P30876; P35269; P36954; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403; Q13888; Q13889; Q6ZYL4; Q92759;
1-210
100MG; 11×ZN;
Human core-PIC in the initial transcribing state Heteromer
O15514; P13984; P19387; P19388; P20226; P23193; P24928; P29083; P29084; P30876; P35269; P36954; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403;
1-210
100MG; 11×ZN;
Structure of the human Mediator-bound transcription pre-initiation complex Heteromer
A0JLT2; O15514; O43513; O60244; O75448; O75586; P13984; P18074; P19387; P19388; P19447; P20226; P24928; P29083; P29084; P30876; P32780; P35269; P36954; P50613; P51946; P51948; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403; Q13503; Q13888; Q13889; Q15528; Q6P2C8; Q6ZYL4; Q71SY5; Q92759; Q96G25; Q96HR3; Q96RN5; Q9BTT4; Q9BUE0; Q9H204; Q9H944; Q9NPJ6; Q9NVC6; Q9NWA0; Q9NX70; Q9P086; Q9ULK4; Q9Y2X0; Q9Y3C7;
1-210
100MG; 16×ZN;SF4;
Human core-PIC in the initial transcribing state (no IIS) Heteromer
O15514; P13984; P19387; P19388; P20226; P24928; P29083; P29084; P30876; P35269; P36954; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403;
1-210
100MG; 11×ZN;
Human holo-PIC in the closed state Heteromer
O15514; P13984; P18074; P19387; P19388; P19447; P20226; P23193; P24928; P29083; P29084; P30876; P32780; P35269; P36954; P50613; P51946; P51948; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403; Q13888; Q13889; Q6ZYL4; Q92759;
1-210
100MG; 17×ZN;SF4;
Human core-PIC in the closed state Heteromer
O15514; P13984; P19387; P19388; P20226; P23193; P24928; P29083; P29084; P30876; P35269; P36954; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403;
1-210
100MG; 11×ZN;
cryo-EM structure of human RNA polymerase III in elongating state Heteromer
O14802; O15160; O15318; O75575; P05423; P0DPB6; P19388; P52434; P53803; P61218; P62875; Q9BUI4; Q9H1D9; Q9NVU0; Q9NW08; Q9Y2Y1; Q9Y535;
1-210
100ZN;SF4;
Cryo-EM structure of human RNA Polymerase III elongation complex 2 Heteromer
O14802; O15160; O15318; O75575; P05423; P0DPB6; P19388; P52434; P53803; P61218; P62875; Q9BUI4; Q9H1D9; Q9NVU0; Q9NW08; Q9Y2Y1; Q9Y535;
2-210
100ZN;SF4;MG;
human Pol III pre-termination complex Heteromer
O14802; O15160; O15318; O75575; P05423; P0DPB6; P19388; P52434; P53803; P61218; P62875; Q9BUI4; Q9H1D9; Q9NVU0; Q9NW08; Q9Y2Y1; Q9Y535;
2-210
100MG;ZN;SF4;
human Pol III elongation complex Heteromer
O14802; O15160; O15318; O75575; P05423; P0DPB6; P19388; P52434; P53803; P61218; P62875; Q9BUI4; Q9H1D9; Q9NVU0; Q9NW08; Q9Y2Y1; Q9Y535;
2-210
100ZN;SF4;
Cryo-EM structure of human RNA Polymerase III elongation complex 3 Heteromer
O14802; O15160; O15318; O75575; P05423; P0DPB6; P19388; P52434; P53803; P61218; P62875; Q9BUI4; Q9H1D9; Q9NVU0; Q9NW08; Q9Y2Y1; Q9Y535;
2-210
100ZN;SF4;MG;
Cryo-EM structure of human RNA Polymerase I in elongation state Heteromer
O15160; O15446; O95602; P0DPB6; P19388; P52434; P53803; P61218; P62875; Q3B726; Q9GZS1; Q9H9Y6; Q9P1U0;
2-210
99.52ZN;MG;
human RNA polymerase III pre-initiation complex closed DNA 1 Heteromer
A6H8Y1; O14802; O15160; O15318; O75575; P05423; P0DPB6; P19388; P20226; P52434; P53803; P61218; P62875; Q16533; Q5SXM2; Q92966; Q9BUI4; Q9H1D9; Q9HAW0; Q9NVU0; Q9NW08; Q9Y2Y1; Q9Y535;
2-210
100ZN;MG;SF4;
RNA polymerase III pre-initiation complex open complex 1 Heteromer
A6H8Y1; O14802; O15160; O15318; O75575; P05423; P0DPB6; P19388; P20226; P52434; P53803; P61218; P62875; Q16533; Q5SXM2; Q92966; Q9BUI4; Q9H1D9; Q9HAW0; Q9NVU0; Q9NW08; Q9Y2Y1; Q9Y535;
2-210
100ZN;MG;SF4;
RNA polymerase III pre-initiation complex melting complex 1 Heteromer
A6H8Y1; O14802; O15160; O15318; O75575; P05423; P0DPB6; P19388; P20226; P52434; P53803; P61218; P62875; Q16533; Q5SXM2; Q92966; Q9BUI4; Q9H1D9; Q9HAW0; Q9NVU0; Q9NW08; Q9Y2Y1; Q9Y535;
2-210
100ZN;MG;SF4;
Cryo-EM structure of human apo RNA Polymerase III Heteromer
O14802; O15160; O15318; O75575; P05423; P0DPB6; P19388; P52434; P53803; P61218; P62875; Q9BUI4; Q9H1D9; Q9NVU0; Q9NW08; Q9Y2Y1; Q9Y535;
2-210
100ZN;MG;SF4;
Cryo-EM structure of human RNA Polymerase III elongation complex 1 Heteromer
O14802; O15160; O15318; O75575; P05423; P0DPB6; P19388; P52434; P53803; P61218; P62875; Q9BUI4; Q9H1D9; Q9NVU0; Q9NW08; Q9Y2Y1; Q9Y535;
2-210
100ZN;SF4;MG;
Human RNA polymerase I Heteromer
O15160; O15446; O95602; P0DPB6; P19388; P52434; P53803; P61218; P62875; Q9GZS1; Q9H9Y6; Q9P1U0;
2-210
100
Apo Human RNA Polymerase III Heteromer
O14802; O15160; O75575; P05423; P0DPB6; P19388; P52434; P53803; P61218; P62875; Q9BUI4; Q9H1D9; Q9NVU0; Q9NW08; Q9Y2Y1; Q9Y535;
2-210
100
Structure of the pre state human RNA Polymerase I Elongation Complex Heteromer
O15160; O15446; O95602; P0DPB6; P19388; P52434; P53803; P61218; P62875; Q3B726; Q9GZS1; Q9H9Y6; Q9P1U0;
4-210
100.0ZN;MG;2TM;
Structure of the post state human RNA Polymerase I Elongation Complex Heteromer
O15160; O15446; O95602; P0DPB6; P19388; P52434; P53803; P61218; P62875; Q3B726; Q9GZS1; Q9H9Y6; Q9P1U0;
4-210
100.0ZN;MG;
Back track state of human RNA Polymerase I Elongation Complex Heteromer
O15160; O15446; O95602; P0DPB6; P19388; P52434; P53803; P61218; P62875; Q3B726; Q9GZS1; Q9H9Y6; Q9P1U0;
4-210
100.0ZN;MG;
Structure of the p53/RNA polymerase II assembly Heteromer
O15514; P04637; P19387; P19388; P24928; P30876; P36954; P52434; P52435; P53803; P61218; P62487; P62875;
4-210
100MG;ZN;
RNA polymerase III EC complex in post-translocation state Heteromer
O14802; O15160; O15318; O75575; P05423; P0DPB6; P19388; P52434; P53803; P61218; P62875; Q9BUI4; Q9H1D9; Q9NVU0; Q9NW08; Q9Y2Y1; Q9Y535;
6-210
100.0MG;ZN;SF4;
Structure of Human RNA Polymerase III elongation complex Heteromer
O14802; O15160; O15318; O75575; P05423; P0DPB6; P19388; P52434; P53803; P61218; P62875; Q9BUI4; Q9H1D9; Q9NVU0; Q9NW08; Q9Y2Y1; Q9Y535;
6-210
100.0MG;ZN;SF4;
RNA Pol II(G) Heteromer
O15514; P0CAP2; P19387; P19388; P24928; P30876; P36954; P52434; P52435; P53803; P61218; P62487; P62875;
6-210
98.38ZN;

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
5iyd.1.Emonomer0.791-210
100.00